Breaking News, Collaborations & Alliances

GL Chemtec Partners with Edgewater Capital to Accelerate Growth

Investment in response to increased demand for North American-based chemistry services.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GL Chemtec (GLC), a specialist in advanced chemistry R&D and scale-up services to support active pharmaceutical ingredient (API) development, and the development of advanced materials for drug delivery, medical devices and other life science applications, is partnering with Edgewater Capital Partners, a lower middle-market private equity firm with deep sector expertise in life sciences and pharma services, accelerating the company’s growth as a North American chemistry-based contract researc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters